Αρχική World News Adding Apalutamide to Perioperative ADT Associated with Better Outcomes of Radical Prostatectomy... World News Adding Apalutamide to Perioperative ADT Associated with Better Outcomes of Radical Prostatectomy for High-Risk Localised or Locally Advanced Prostate Cancer Από Ogkologos - 3 Ιουνίου, 2026 311 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PROTEUS study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Same Breast Cancer, Same Place, Same Treatment. This Mother and Daughter... 7 Μαΐου, 2021 Tucatinib and Trastuzumab Combination Approved for Advanced Colorectal Cancer 10 Φεβρουαρίου, 2023 ΚΑΡΚΙΝΟΣ ΤΟΥ ΠΕΟΥΣ 10 Φεβρουαρίου, 2019 Woman Helps Students With Special Needs Achieve Success After Graduation 23 Δεκεμβρίου, 2021 Φόρτωση περισσοτέρων HOT NEWS ESMO’s Expert Consensus: Do Not Discontinue or Delay Cancer Treatment That... Artificial Intelligence Brings Pancreatic Cancer Screening One Step Closer to Reality... FDA Recognises OncoKB Database of Molecular Tumour Marker Information Brentuximab May Mean Less Radiation for Children, Teens with Hodgkin Lymphoma